Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin
- 1 February 1999
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 17 (1) , 17-27
- https://doi.org/10.1023/a:1006267517726
Abstract
A highly active and broadly active thioxanthone has been identified: N-[[1-[[2-(Diethylamino)ethyl]amino]-7-methoxy-9-oxo-9H-thioxanthen-4-yl] methylformamide (SR271425, BCN326862, WIN71425). In...Keywords
This publication has 13 references indexed in Scilit:
- Synthesis and Antitumor Activity of 4-Aminomethylthioxanthenone and 5-Aminomethylbenzothiopyranoindazole DerivativesJournal of Medicinal Chemistry, 1998
- Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity.1997
- In Vivo Methods for Screening and Preclinical TestingPublished by Springer Nature ,1997
- Cyclic variations of SR 233377 (WIN 33377) and effects on antitumor activityBioorganic & Medicinal Chemistry Letters, 1996
- Tumor Models and the Discovery and Secondary Evaluation of Solid Tumor Active AgentsInternational Journal of Pharmacognosy, 1995
- Antitumour activity of N-[[1-[[2-(diethylamino)ethyl]amino]-9-oxo-9H-thioxanthen-4-yl]methyl]methanesulfonamide (WIN33377) and analoguesExpert Opinion on Investigational Drugs, 1994
- Rhodamine efflux patterns predict P-glycoprotein substrates in the National Cancer Institute drug screen.1994
- Comparative Molecular Field Analysis of the Antitumor Activity of 9H-Thiioxanthen-9-one Derivatives against Pancreatic Ductal Carcinoma 03Journal of Medicinal Chemistry, 1994
- Anti-solid tumor efficacy and preparation of N-[[1-[[2-(diethylamino)ethyl]amino]-9-oxo-9H-thioxanthen-4-yl]methyl]methanesulfonamide (win 33377) and related derivativesBioorganic & Medicinal Chemistry Letters, 1994
- ANTITUMOR EFFICACY OF PD115934 (NSC 366140) AGAINST SOLID TUMORS OF MICE1990